Bioprospection of rattlesnake venom peptide fractions with anti-adipose and anti-insulin resistance activity
Adipocyte lipid accumulation
Bioactive peptides
Crotalus
Crotamine-like peptides
Insulin resistance
Venom
Journal
Toxicon: X
ISSN: 2590-1710
Titre abrégé: Toxicon X
Pays: England
ID NLM: 101741983
Informations de publication
Date de publication:
Dec 2024
Dec 2024
Historique:
received:
05
06
2024
revised:
10
09
2024
accepted:
11
09
2024
medline:
14
10
2024
pubmed:
14
10
2024
entrez:
14
10
2024
Statut:
epublish
Résumé
Animal venoms are natural products that have served as a source of novel molecules that have inspired novel drugs for several diseases, including for metabolic diseases such as type-2 diabetes and obesity. From venoms, toxins such as exendin-4 (
Identifiants
pubmed: 39398348
doi: 10.1016/j.toxcx.2024.100209
pii: S2590-1710(24)00026-2
pmc: PMC11471244
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100209Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Our research work has received financial support from CONACyT (Mexican 10.13039/501100003141National Council of Humanities, Sciences and Technologies), as part of the “Ciencia de Frontera 2023” grant (CF-2023-I-2019). CONACyT has not participated in any way in the definition, execution, and validation of the results of the project. CONACyT, as a governmental agency, focuses on promoting scientific and technological development in Mexico, having no commercial activity. Therefore, CONACyT holds no commercial interest in the results of the project, nor has any influence on such results. In this context, this external funding does not represent a competing financial interest.